3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
13
Rectal Neoplasms
4
Neoplasm Metastasis
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Advanced Solid Tumors
2
Stomach Neoplasms
1
Solid Tumor Cancer
1
Sarcoma, Ewing
1
Sarcoma
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Microsatellite-stable Colorectal Cancer
1
Metastatic Gastric Adenocarcinoma
1
Lung Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Craniopharyngioma
1
Colorectal Cancer Metastatic
1
Breast Neoplasms
1
Anal Cancer Metastatic
1
Advanced Microsatellite Stable Colorectal Cancer
1
Adenomatous Polyposis Coli
1
Interventions
Cisplatin
18
Gemcitabine
14
Radiotherapy, Intensity-Modulated
11
Magnetic Resonance Spectroscopy
8
toripalimab
7
Specimen Handling
7
Capecitabine
7
Platinum
5
Drug Therapy
5
1,2-diaminocyclohexaneplatinum II citrate
5
camrelizumab
4
Radiotherapy
4
Nivolumab
4
spartalizumab
3
sintilimab
3
anlotinib
3
Immunoglobulin G
3
Immune Checkpoint Inhibitors
3
Docetaxel
3
Disulfides
3
atezolizumab
2
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
Bevacizumab
2
18-O-demethylcervinomycin A2
2
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
trifluridine tipiracil drug combination
×
90 days
×
Clear all
No trials found.